Prescription Rates and Prognostic Implications of Optimally Targeted Guideline-Directed Medical Treatment in Heart Failure and Atrial Fibrillation: Insights From The MISOAC-AF Trial

*First Department of Cardiology, Faculty of Health Sciences, School of Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece;

†Department of Informatics and Telecommunication Engineering, University of Western Macedonia, Kozani, Greece; and

‡Interbalkan European Medical Center, Thessaloniki, Greece.

Correspondence: George Giannakoulas, MD, PhD, First Department of Cardiology, AHEPA University Hospital, Aristotle University of Thessaloniki, St Kiriakidi 1, 54636 Thessaloniki, Greece (e-mail: [email protected]).

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

The authors report no conflicts of interest.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jcvp.org).

留言 (0)

沒有登入
gif